Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Atwood

Showing results (51-60 of 197) with videos related to

Pageof 20
Sort By:
Brain Research. Brain Research Reviews|September 23, 2003
Cerebrovascular requirement for sealant, anti-coagulant and remodeling molecules that allow for the maintenance of vascular integrity and blood supplyCraig S Atwood, Richard L Bowen, Mark A Smith, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|June 30, 2000
The role of metals in neurodegenerative diseasesL M Sayre, G Perry, C S Atwood, et al.
Acta Neuropathologica|June 19, 2002
Dangers of the amyloid-beta vaccinationMark A Smith, James A Joseph, Craig S Atwood, et al.
Endocrine|July 22, 2005
The gonadotropin connection in Alzheimer's diseaseSivan Vadakkadath Meethal, Mark A Smith, Richard L Bowen, et al.
Expert Opinion on Investigational Drugs|November 1, 2007
Leuprolide acetate: a drug of diverse clinical applicationsAndrea C Wilson, Sivan Vadakkadath Meethal, Richard L Bowen, et al.
Current Pharmaceutical Design|February 14, 2006
Antigonadotropins: a novel strategy to halt Alzheimer's disease progressionChristopher W Gregory, Craig S Atwood, Mark A Smith, et al.
Geroscience|March 9, 2017
Does the degree of endocrine dyscrasia post-reproduction dictate post-reproductive lifespan? Lessons from semelparous and iteroparous speciesCraig S Atwood, Kentaro Hayashi, Sivan Vadakkadath Meethal, et al.
Journal of Alzheimer'S Disease : JAD|October 15, 2014
A clinical study of lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose lupron over 48 weeksRichard L Bowen, George Perry, Chengjie Xiong, et al.
Journal of Alzheimer'S Disease : JAD|September 6, 2002
Could Abeta and AbetaPP be Antioxidants?Ashley I. Bush, Craig S. Atwood, Lee E. Goldstein, et al.
Neurotoxicity Research|June 28, 2003
Involvement of Maillard reactions in Alzheimer diseaseV Prakash Reddy, Mark E Obrenovich, Craig S Atwood, et al.
Pageof 20

Showing results (51-60 of 197) with videos related to

Sort By:
Pageof 20
Brain Research. Brain Research Reviews|September 23, 2003
Cerebrovascular requirement for sealant, anti-coagulant and remodeling molecules that allow for the maintenance of vascular integrity and blood supplyCraig S Atwood, Richard L Bowen, Mark A Smith, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|June 30, 2000
The role of metals in neurodegenerative diseasesL M Sayre, G Perry, C S Atwood, et al.
Acta Neuropathologica|June 19, 2002
Dangers of the amyloid-beta vaccinationMark A Smith, James A Joseph, Craig S Atwood, et al.
Endocrine|July 22, 2005
The gonadotropin connection in Alzheimer's diseaseSivan Vadakkadath Meethal, Mark A Smith, Richard L Bowen, et al.
Expert Opinion on Investigational Drugs|November 1, 2007
Leuprolide acetate: a drug of diverse clinical applicationsAndrea C Wilson, Sivan Vadakkadath Meethal, Richard L Bowen, et al.
Current Pharmaceutical Design|February 14, 2006
Antigonadotropins: a novel strategy to halt Alzheimer's disease progressionChristopher W Gregory, Craig S Atwood, Mark A Smith, et al.
Geroscience|March 9, 2017
Does the degree of endocrine dyscrasia post-reproduction dictate post-reproductive lifespan? Lessons from semelparous and iteroparous speciesCraig S Atwood, Kentaro Hayashi, Sivan Vadakkadath Meethal, et al.
Journal of Alzheimer'S Disease : JAD|October 15, 2014
A clinical study of lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose lupron over 48 weeksRichard L Bowen, George Perry, Chengjie Xiong, et al.
Journal of Alzheimer'S Disease : JAD|September 6, 2002
Could Abeta and AbetaPP be Antioxidants?Ashley I. Bush, Craig S. Atwood, Lee E. Goldstein, et al.
Neurotoxicity Research|June 28, 2003
Involvement of Maillard reactions in Alzheimer diseaseV Prakash Reddy, Mark E Obrenovich, Craig S Atwood, et al.
Pageof 20